fingolimod hydrochloride has been researched along with Brain Hemorrhage, Cerebral in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Dong, S; Tan, X; Yan, B; Yang, Z; Zhang, L; Zheng, Q; Zou, J | 1 |
| Ducruet, AF; Lawton, MT; Qiu, S; Sheth, KN; Shi, E; Shi, K | 1 |
| Ayata, C; Barfejani, AH; Dong, Q; Lu, L; Qin, T; Waeber, C | 1 |
| Fu, Y; Hao, J; Huang, D; Li, YJ; Ren, L; Shi, FD; Sun, N; Yan, Y; Yu, C; Zhang, N | 1 |
| Rosand, J; Sheth, KN | 1 |
| Chang, GQ; Fu, Y; Gong, Y; Li, YJ; Liu, Y; Shi, FD; Wood, K; Yan, Y; Yang, C | 1 |
| Bester, M; Gerloff, C; Heesen, C; Leypoldt, F; Moeller, F; Münchau, A | 1 |
| Hasegawa, Y; Lekic, T; Manaenko, A; Ostrowski, R; Rolland, WB; Tang, J; Zhang, JH | 1 |
| Baer, K; Frevert, U; Kappe, SH; Mikolajczak, SA; Movila, A; Nacer, A | 1 |
| Altay, O; Hartman, R; Hasegawa, Y; Krafft, PR; Lekic, T; Manaenko, A; Ostrowski, R; Rolland, WB; Tang, J; Zhang, JH | 1 |
| Arai, K; Campos, F; Castillo, J; Lo, EH; Qin, T; Seo, JH; Waeber, C | 1 |
2 trial(s) available for fingolimod hydrochloride and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study.
Topics: Aged; Cerebral Hemorrhage; Female; Fingolimod Hydrochloride; Glasgow Coma Scale; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Propylene Glycols; Recovery of Function; Severity of Illness Index; Single-Blind Method; Sphingosine; Treatment Outcome | 2014 |
Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage.
Topics: Capillary Permeability; Cell Separation; Cerebral Hemorrhage; Cytokines; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Inflammation Mediators; Lymphocytes; Single-Blind Method | 2015 |
9 other study(ies) available for fingolimod hydrochloride and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
FTY720 attenuates iron deposition and glial responses in improving delayed lesion and long-term outcomes of collagenase-induced intracerebral hemorrhage.
Topics: Animals; Brain; Brain Injuries; Cerebral Hemorrhage; Disease Models, Animal; Fingolimod Hydrochloride; Gliosis; Inflammation; Iron; Male; Mice; Mice, Inbred ICR; Neuroglia; Neuroprotective Agents | 2019 |
Chronic inflammation, cognitive impairment, and distal brain region alteration following intracerebral hemorrhage.
Topics: Aminopyridines; Animals; Brain; Cerebral Hemorrhage; Cognition; Cognitive Dysfunction; Disease Models, Animal; Fingolimod Hydrochloride; Flow Cytometry; Hippocampus; Inflammation; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroimaging; Neuronal Plasticity; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2019 |
Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage.
Topics: Animals; Apoptosis; Brain Edema; Cerebral Hemorrhage; Disease Models, Animal; Fingolimod Hydrochloride; Hematoma; Male; Mice; Neuroprotective Agents; Propylene Glycols; Sphingosine; Weight Loss | 2014 |
Targeting the immune system in intracerebral hemorrhage.
Topics: Cerebral Hemorrhage; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Propylene Glycols; Sphingosine | 2014 |
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
Topics: Adult; Brain; Cerebral Hemorrhage; Contrast Media; Encephalitis; Epilepsy, Complex Partial; Female; Fingolimod Hydrochloride; Gadolinium; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis, Relapsing-Remitting; Necrosis; Propylene Glycols; Sphingosine | 2009 |
FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice.
Topics: Analysis of Variance; Animals; Brain Edema; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Fingolimod Hydrochloride; Functional Laterality; Immunosuppressive Agents; Mice; Nervous System Diseases; Neurologic Examination; Propylene Glycols; Psychomotor Performance; Sphingosine; Time Factors | 2011 |
Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
Topics: Animals; Benzamides; Blood-Brain Barrier; Cerebral Hemorrhage; Disease Models, Animal; Fingolimod Hydrochloride; Imatinib Mesylate; Lipopolysaccharide Receptors; Lymphocyte Function-Associated Antigen-1; Malaria, Cerebral; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Neuroimmunomodulation; Parasitemia; Piperazines; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Propylene Glycols; Pyrimidines; Sphingosine | 2012 |
Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage.
Topics: Analysis of Variance; Animals; Basal Ganglia; Behavior, Animal; Blood Transfusion, Autologous; Brain Edema; CD3 Complex; Cell Count; Cerebral Cortex; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Fingolimod Hydrochloride; Forelimb; Functional Laterality; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-17; Leukocytes; Lymphocytes; Male; Maze Learning; Mice; Nervous System Diseases; Propylene Glycols; Psychomotor Disorders; Rats; Rats, Sprague-Dawley; Space Perception; Sphingosine; Time Factors | 2013 |
Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model.
Topics: Animals; Cerebral Hemorrhage; Disease Models, Animal; Fingolimod Hydrochloride; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Propylene Glycols; Sphingosine; Thromboembolism; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2013 |